MENU
MTSR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Metsera (MTSR) Ownership - Who owns Metsera?
Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.53B
P/E Ratio
N/A
Total Cash
530.92M
Projected Growth
N/A
Total Debt
1.06M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.04
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MTSR
Capitalization
5.53B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
531M
Total Cash/Share
5.04
Total Debt
1.06M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
449M
P/B Ratio
12.30
Cash Flow
N/A
Earnings
-2.93
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
5.26
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-316.25M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-48.12
Shares Held By Institutions
5.79B
Shares Outstanding - Current
105M
Total Liabilities
190M
Total Volume MTD
N/A
Value
N/A
Gain YTD
N/A
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MTSR showed earnings on July 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information